Pre-Op Chemo or Upfront Surgery in Colon Cancer: Is One Strategy Best?
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — The use of neoadjuvant chemotherapy failed to improve disease-free survival (DFS) compared with upfront surgery in patients with locally advanced colon cancer, a randomized phase III trial showed. Among 248 patients, the DFS rate at…
